KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Liabilities and Shareholders Equity (2017 - 2026)

Moderna (MRNA) has disclosed Liabilities and Shareholders Equity for 10 consecutive years, with $11.5 billion as the latest value for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity fell 9.57% year-over-year to $11.5 billion; the TTM value through Mar 2026 reached $48.0 billion, down 17.76%, while the annual FY2025 figure was $12.3 billion, 12.76% down from the prior year.
  • Liabilities and Shareholders Equity hit $11.5 billion in Q1 2026 for Moderna, down from $12.3 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $27.6 billion in Q1 2022 and bottomed at $11.5 billion in Q1 2026.
  • Average Liabilities and Shareholders Equity over 5 years is $18.4 billion, with a median of $16.7 billion recorded in 2024.
  • Year-over-year, Liabilities and Shareholders Equity skyrocketed 117.5% in 2022 and then plummeted 30.66% in 2024.
  • Moderna's Liabilities and Shareholders Equity stood at $25.9 billion in 2022, then decreased by 28.74% to $18.4 billion in 2023, then fell by 23.25% to $14.1 billion in 2024, then decreased by 12.76% to $12.3 billion in 2025, then fell by 6.89% to $11.5 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $11.5 billion, $12.3 billion, and $12.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.